Jeff Yass’s BIO-key International BKYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,719
| Closed | -$9.11K | – | 13401 |
|
|
2026
Q1 | $9.11K | Buy |
+1,719
| New | +$10.7K | ﹤0.01% | 12946 |
|
|
2023
Q4 | – | Sell |
-139
| Closed | -$13.1K | – | 12358 |
|
|
2023
Q3 | $13.1K | Hold |
139
| – | – | ﹤0.01% | 11688 |
|
|
2023
Q2 | $19.2K | Buy |
139
+32
| +30% | +$4.26K | ﹤0.01% | 11645 |
|
|
2023
Q1 | $13.5K | Sell |
107
-147
| -58% | -$20.4K | ﹤0.01% | 12150 |
|
|
2022
Q4 | $26.8K | Buy |
254
+87
| +52% | +$18.9K | ﹤0.01% | 11660 |
|
|
2022
Q3 | $46K | Sell |
167
-118
| -41% | -$36.8K | ﹤0.01% | 12248 |
|
|
2022
Q2 | $90K | Sell |
285
-81
| -22% | -$28.7K | ﹤0.01% | 11561 |
|
|
2022
Q1 | $158K | Sell |
366
-179
| -33% | -$72.3K | ﹤0.01% | 11505 |
|
|
2021
Q4 | $215K | Sell |
545
-49
| -8% | -$24.7K | ﹤0.01% | 11290 |
|
|
2021
Q3 | $377K | Sell |
594
-78
| -12% | -$46K | ﹤0.01% | 10066 |
|
|
2021
Q2 | $460K | Buy |
672
+155
| +30% | +$102K | ﹤0.01% | 9776 |
|
|
2021
Q1 | $325K | Buy |
+517
| New | +$373K | ﹤0.01% | 10434 |
|
|
2019
Q4 | – | Sell |
-21
| Closed | -$18K | – | 9723 |
|
|
2019
Q3 | $18K | Buy |
21
+14
| +200% | +$19.2K | ﹤0.01% | 9961 |
|
|
2019
Q2 | $13K | Buy |
+7
| New | +$12.1K | ﹤0.01% | 10049 |
|
Jeff Yass's BKYI Position: Q2 2026 in Review
Jeff Yass sold out of BIO-key International (BKYI) in Q2 2026, closing a stake of 1,719 shares — an estimated $9.11K sold.
Jeff Yass first reported a position in BKYI in Q2 2019 and held it in 14 quarters. The position peaked at $460K in Q2 2021. 0 funds tracked by Wall St. Rank hold BKYI as of Q2 2026.
- Jeff Yass reported no remaining BIO-key International position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 1,719 BIO-key International shares in Q2 2026, an estimated $9.11K.
- Jeff Yass first reported a position in BIO-key International in Q2 2019 and held it in 14 quarters.
- Jeff Yass's BIO-key International position peaked at $460K in Q2 2021.
- 0 funds tracked by Wall St. Rank held BIO-key International as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.